Abstract
Large scale genetic studies such as genome-wide association studies (GWAS) in Parkinson's disease (PD) have revealed genetic susceptibility factors and continue to offer new insights both into the genetics of sporadic disease and its pathogenesis, with the potential for identification of an at-risk population and novel therapeutic targets. However, the methodology importantly requires larger data sets for replication of novel findings.
| Original language | English |
|---|---|
| Number of pages | 0 |
| Journal | Journal of Neurology, Neurosurgery and Psychiatry |
| Volume | 84 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- PARKINSON'S DISEASE
- STROKE
Fingerprint
Dive into the research topics of 'Molecular genetic studies of neurodegenerative disease.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver